In this Section
4035.0 Public Health Response to Personalized Medicine
Tuesday, October 30, 2012: 8:30 AM - 10:00 AM
The use of personalized medicine to diagnose and provide personalized, genomic-based therapies for diseases poses unique scientific, ethical, clinical, and policy opportunities and challenges for public health. There is a need to identify the areas of most benefit and potential challenge to public health. Speakers in this session will present work that overviews the areas of most need to address, including privacy and confidentiality of genetic information, informed decision making around genetic technology and information, and gene patenting. Other speakers will focus on particular health areas pertinent to public health and present research on the utility of genomic information in assessing risk for cardiovascular conditions and asthma, among others.
Session Objectives: Assess the opportunities and benefits of genomic technologies for conditions of public health importance.
Peter Tonellato, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Genomics Forum
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)
See more of: Genomics Forum